Search

Author/Creator Tabernero, David

1. Application of EASL 2017 criteria for switching hepatitis B patients from tenofovir disoproxil to entecavir or tenofovir alafenamide. Issue 10 (October 2020)

Authors:
Roade, Luisa; Loglio, Alessandro; Borghi, Marta; Riveiro-Barciela, Mar; Soffredini, Roberta; Facchetti, Floriana; di Paolo, Dhanai; Tabernero, David; Lunghi, Giovanna; Esteban, Rafael; Buti, Maria; Lampertico, Pietro
Journal:
Digestive and liver disease
Issue:
Volume 52:Issue 10(2020)
Page Start:
1164
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Next-generation sequencing for the diagnosis of hepatitis B: current status and future prospects. (3rd April 2021)

Authors:
Garcia-Garcia, Selene; Cortese, Maria Francesca; Rodríguez-Algarra, Francisco; Tabernero, David; Rando-Segura, Ariadna; Quer, Josep; Buti, Maria; Rodríguez-Frías, Francisco
Journal:
Expert review of molecular diagnostics
Issue:
Volume 21:Number 4(2021)
Page Start:
381
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Resistance‐associated substitutions after sofosbuvir/velpatasvir/voxilaprevir triple therapy failure. Issue 9 (22nd March 2021)

Authors:
Garcia‐Cehic, Damir; Rando, Ariadna; Rodriguez‐Frias, Francisco; Gregori, Josep; Costa, Juan Garcia; Carrión, José Antonio; Macenlle, Ramiro; Pamplona, Javier; Castro‐Iglesias, Angeles; Cañizares, Angelina; Tabernero, David; Campos, Carolina; Buti, Maria; Esteban, Juan Ignacio; Quer, Josep
Journal:
Journal of viral hepatitis
Issue:
Volume 28:Issue 9(2021)
Page Start:
1319
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗